5th Dec 2016 12:00
Mediclinic International plc (Incorporated in England and Wales)Company Number: 08338604LSE Share Code: MDCJSE Share Code: MEINSX Share Code: MEPISIN: GB00B8HX8Z88
5 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
|
| |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | MEDICLINIC INTERNATIONAL PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | X | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||
An event changing the breakdown of voting rights |
| |||
Other (please specify): |
|
| ||
3. Full name of person(s) subject to thenotification obligation: | PUBLIC INVESTMENT CORPORATION SOC LIMITED | |||
4. Full name of shareholder(s) (if different from 3.): | N/A | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 01 December 2016 | |||
6. Date on which issuer notified: | 02 December 2016 | |||
7. Threshold(s) that is/are crossed orreached: | 8% | |||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||||||||
MEI ORDINARY SHARES | 59 239 493 |
| 58 705 799 |
|
| 7.963% |
| ||||||||||
| |||||||||||||||||
| |||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
NONE | N/A | N/A | N/A | N/A | |||||||||||||
| |||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| ||||||||||||
|
|
|
|
| Nominal | Delta | |||||||||||
|
| ||||||||||||||||
| |||||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
58 705 799 | 7.963% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
N/A | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
| ||
13. Additional information: | N/A | |
14. Contact name: | DEVILLIERS MAKONKO | |
15. Contact telephone number: | 012 742 3578 | |
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Related Shares:
MDC.L